{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:58:22Z","timestamp":1789628302252,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82130101"],"award-info":[{"award-number":["82130101"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004739","name":"Youth Innovation Promotion Association of the Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["2021333"],"award-info":[{"award-number":["2021333"]}],"id":[{"id":"10.13039\/501100004739","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010096","name":"Southern Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010096","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virologica Sinica"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.virs.2025.05.009","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T19:18:01Z","timestamp":1748459881000},"page":"439-450","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Eltrombopag, an FDA-approved drug, inhibits dengue virus type 2 by targeting NS2B-NS3 protease"],"prefix":"10.1016","volume":"40","author":[{"given":"Xuerui","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenshu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongfa","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gengfu","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0553-5138","authenticated-orcid":false,"given":"Xiaoyan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virs.2025.05.009_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1\u20132","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"10.1016\/j.virs.2025.05.009_bib2","doi-asserted-by":"crossref","first-page":"W530","DOI":"10.1093\/nar\/gkab294","article-title":"PLIP 2021: expanding the scope of the protein-ligand interaction profiler to DNA and RNA","volume":"49","author":"Adasme","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.virs.2025.05.009_bib3","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3390\/pathogens11080879","article-title":"AG129 mice as a Comprehensive model for the experimental Assessment of mosquito Vector competence for Arboviruses","volume":"11","author":"Baldon","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.virs.2025.05.009_bib4","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.virs.2025.05.009_bib5","article-title":"Investigation of the efficacy and safety of eltrombopag to correct thrombocytopenia in moderate to severe dengue patients - a phase II randomized controlled clinical trial","volume":"29\u201330","author":"Chakraborty","year":"2020","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.virs.2025.05.009_bib6","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: new docking methods, Expanded force field, and Python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.virs.2025.05.009_bib7","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1634\/stemcells.2008-0366","article-title":"Preclinical activity of eltrombopag (SB-497115), an oral, nonpeptide thrombopoietin receptor agonist","volume":"27","author":"Erickson-Miller","year":"2009","journal-title":"Stem Cell."},{"key":"10.1016\/j.virs.2025.05.009_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1418516","article-title":"Recent advances in the study of zika virus structure, drug targets, and inhibitors","volume":"15","author":"Feng","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.virs.2025.05.009_bib9","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s10900-016-0177-7","article-title":"The Convergence of a virus, Mosquitoes, and human Travel in Globalizing the zika epidemic","volume":"41","author":"Imperato","year":"2016","journal-title":"J. Community Health"},{"key":"10.1016\/j.virs.2025.05.009_bib10","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1126\/science.aan6836","article-title":"Antibody-dependent enhancement of severe dengue disease in humans","volume":"358","author":"Katzelnick","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.virs.2025.05.009_bib11","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.3390\/antibiotics10111372","article-title":"Repurposing eltrombopag for Multidrug resistant Staphylococcus aureus infections","volume":"10","author":"Lee","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.virs.2025.05.009_bib12","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/cr.2017.88","article-title":"Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction","volume":"27","author":"Li","year":"2017","journal-title":"Cell Res."},{"key":"10.1016\/j.virs.2025.05.009_bib13","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.antiviral.2017.12.018","article-title":"Erythrosin B is a potent and broad-spectrum orthosteric inhibitor of the flavivirus NS2B-NS3 protease","volume":"150","author":"Li","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virs.2025.05.009_bib14","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.antiviral.2018.12.016","article-title":"Dengue drug discovery: Progress, challenges and outlook","volume":"163","author":"Lim","year":"2019","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virs.2025.05.009_bib15","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.antiviral.2015.03.014","article-title":"The flavivirus NS2B-NS3 protease-helicase as a target for antiviral drug development","volume":"118","author":"Luo","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virs.2025.05.009_bib16","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/s41564-019-0476-8","article-title":"The current and future global distribution and population at risk of dengue","volume":"4","author":"Messina","year":"2019","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.virs.2025.05.009_bib17","first-page":"299","article-title":"Epidemiology of dengue: past, present and future prospects","volume":"5","author":"Murray","year":"2013","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.virs.2025.05.009_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.580096","article-title":"Intrinsic ADE: the dark side of antibody dependent enhancement during dengue infection","volume":"10","author":"Narayan","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.virs.2025.05.009_bib19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/vbz.2019.2477","article-title":"Differences in the Transmission of dengue fever by different serotypes of dengue virus","volume":"20","author":"Niu","year":"2020","journal-title":"Vector Borne Zoonotic Dis."},{"key":"10.1016\/j.virs.2025.05.009_bib20","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1128\/JVI.02447-07","article-title":"Yellow Fever virus NS3 plays an essential role in virus assembly independent of its known enzymatic functions","volume":"82","author":"Patkar","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.virs.2025.05.009_bib21","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0140-6736(23)02576-X","article-title":"Dengue","volume":"403","author":"Paz-Bailey","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.virs.2025.05.009_bib22","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1126\/science.4023707","article-title":"Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution","volume":"229","author":"Rice","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.virs.2025.05.009_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.add2420","article-title":"Exacerbated Zika virus-induced neuropathology and microcephaly in fetuses of dengue-immune nonhuman primates","volume":"15","author":"Saron","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.virs.2025.05.009_bib24","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.3389\/fmicb.2016.01685","article-title":"Rapid detection strategies for the global threat of zika virus: current state, new Hypotheses, and limitations","volume":"7","author":"Shukla","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.virs.2025.05.009_bib25","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.3390\/ijms25084376","article-title":"The inhibition of NS2B\/NS3 protease: a new therapeutic Opportunity to Treat dengue and zika virus infection","volume":"25","author":"Starvaggi","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.virs.2025.05.009_bib26","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1158\/2159-8290.CD-18-0903","article-title":"Single and dual targeting of Mutant EGFR with an allosteric inhibitor","volume":"9","author":"To","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.virs.2025.05.009_bib27","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.virs.2025.05.009_bib28","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1182\/blood-2016-10-740241","article-title":"Eltrombopag: a powerful chelator of cellular or extracellular iron(III) alone or combined with a second chelator","volume":"130","author":"Vlachodimitropoulou","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.virs.2025.05.009_bib29","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.antiviral.2009.10.008","article-title":"Present and future arboviral threats","volume":"85","author":"Weaver","year":"2010","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virs.2025.05.009_bib30","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1016\/S1473-3099(18)30494-8","article-title":"Deliberations of the strategic Advisory group of Experts on Immunization on the use of CYD-TDV dengue vaccine","volume":"19","author":"Wilder-Smith","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.virs.2025.05.009_bib31","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.vaccine.2016.10.070","article-title":"Dengue vaccine: WHO position paper, July 2016 - recommendations","volume":"35","author":"World Health Organization","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.virs.2025.05.009_bib32","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/aps.2015.56","article-title":"Policresulen, a novel NS2B\/NS3 protease inhibitor, effectively inhibits the replication of DENV2 virus in BHK-21 cells","volume":"36","author":"Wu","year":"2015","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.virs.2025.05.009_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106269","article-title":"Allosteric quinoxaline-based inhibitors of the flavivirus NS2B\/NS3 protease","volume":"131","author":"Zephyr","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.virs.2025.05.009_bib34","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.clinthera.2011.10.004","article-title":"Eltrombopag: an oral thrombopoietin receptor agonist for the treatment of idiopathic thrombocytopenic purpura","volume":"33","author":"Zhang","year":"2011","journal-title":"Clin. Ther."}],"container-title":["Virologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1995820X25000677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1995820X25000677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T10:36:25Z","timestamp":1762598185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1995820X25000677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1995820X25000677"],"URL":"https:\/\/doi.org\/10.1016\/j.virs.2025.05.009","relation":{},"ISSN":["1995-820X"],"issn-type":[{"value":"1995-820X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eltrombopag, an FDA-approved drug, inhibits dengue virus type 2 by targeting NS2B-NS3 protease","name":"articletitle","label":"Article Title"},{"value":"Virologica Sinica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virs.2025.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd\u00e9","name":"copyright","label":"Copyright"}]}}